0001062993-19-002779.txt : 20190702
0001062993-19-002779.hdr.sgml : 20190702
20190702144539
ACCESSION NUMBER: 0001062993-19-002779
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190701
FILED AS OF DATE: 20190702
DATE AS OF CHANGE: 20190702
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gitman Paul
CENTRAL INDEX KEY: 0001375378
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34236
FILM NUMBER: 19936720
MAIL ADDRESS:
STREET 1: 167 EXECUTIVE DRIVE
CITY: MANHASSET HILLS
STATE: NY
ZIP: 11040
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP
CENTRAL INDEX KEY: 0000875622
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 113054851
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 WILBUR ST
CITY: LYNBROOK
STATE: NY
ZIP: 11563
BUSINESS PHONE: 5165937000
MAIL ADDRESS:
STREET 1: 35 WILBUR STREET
CITY: LYNBROOK
STATE: NY
ZIP: 11563
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4
2019-07-01
0000875622
BIOSPECIFICS TECHNOLOGIES CORP
BSTC
0001375378
Gitman Paul
C/O BIOSPECIFICS TECHNOLOGIES CORP.
35 WILBUR STREET
LYNBROOK
NY
11563
1
0
0
0
Common Stock, $0.001 par value
2019-07-01
4
A
0
1890
0.00
A
16890
D
Grant of restricted stock units under the BioSpecifics Technologies Corp. 2019 Omnibus Incentive Compensation Plan.
/s/ Paul Gitman, by Carl A. Valenstein, attorney-in-fact
2019-07-02